Novoglia, Inc. was awarded a $1.4 million award to support the development of a cell therapy for the treatment of ALSP. Pictured are Novoglia, Inc. co-founders Sunil Gandhi, PhD, Robert Spitale, PhD, and Mathew Blurton-Jones, PhD. September 29, 2023 South San Francisco, CA – The California Institute for Regenerative Medicine (CIRM), the world’s largest institution … Continue reading CIRM invests nearly $44 million to advance regenerative medicine research and manufacturing in California
CIRM Joins #GoGold Childhood Cancer Awareness Campaign
Photo courtesy of Stanford Medicine September is Childhood Cancer Awareness Month and the California Institute for Regenerative Medicine (CIRM) is joining the campaign to #GoGold to raise awareness about childhood cancers and highlight our commitment to funding childhood cancer research. The Impact of Childhood Cancer Cancer remains the number one cause of death by disease for … Continue reading CIRM Joins #GoGold Childhood Cancer Awareness Campaign
CIRM’s Annual SPARK Conference Showcases the Trailblazers of Tomorrow
More than 110 student scientists from around California showcased their enthusiasm, passion and “spark” for regenerative medicine and stem cell research at this year’s annual CIRM SPARK Conference. Hosted by Cedars Sinai from Aug. 8-9 in Los Angeles, this year’s event showcased the extraordinary potential of high school students who are poised to become the … Continue reading CIRM’s Annual SPARK Conference Showcases the Trailblazers of Tomorrow
Universal donor stem cells could one day provide lifesaving therapy for lethal brain conditions
Yanhong Shi, Ph.D., Beckman Research Institute of City of Hope. Progress is being made to treat cancer patients suffering from degenerative brain diseases. Scientists at City of Hope, one of the largest cancer research and treatment organizations in the United States, have developed universal donor stem cells that could one day provide lifesaving therapy to … Continue reading Universal donor stem cells could one day provide lifesaving therapy for lethal brain conditions
Finding solutions for affordable and accessible cell and gene therapies
The California Institute for Regenerative Medicine (CIRM) is not alone in seeking a way to make cell and gene therapies more affordable and accessible. The Innovative Genomics Institute (IGI) just completed a year-long effort to consider how treatments could be made more accessible. This effort involved creating a task force comprised of 30 participants to … Continue reading Finding solutions for affordable and accessible cell and gene therapies
CIRM invests $50 million in clinical research, including trial for vision loss
The California Institute for Regenerative Medicine (CIRM), the world’s largest institution dedicated to regenerative medicine, today awarded $50.1 million to fund clinical-stage research projects aimed at advancing stem cell and gene therapy treatments for a variety conditions ranging from neurodegenerative diseases and blood cancers to HIV/AIDS. The awards will support six projects in the Agency’s … Continue reading CIRM invests $50 million in clinical research, including trial for vision loss
Kevin Xu joins governing board of California’s Stem Cell & Gene Therapy Agency
The California Institute for Regenerative Medicine (CIRM), the world’s largest institution dedicated to regenerative medicine, is pleased to announce the appointment of Kevin Xu to its Independent Citizens’ Oversight Committee (ICOC), the official governing Board of the agency. Xu is CEO of MEBO International, an intellectual property management company responsible for managing “Human Body Regenerative … Continue reading Kevin Xu joins governing board of California’s Stem Cell & Gene Therapy Agency
Novartis acquisition validates CIRM’s impact on cystinosis treatment
Dr. Stephanie Cherqui The future looks brighter for cystinosis patients and their families. As one of 7,000 rare diseases, cystinosis causes an abnormal build-up of the amino acid cystine that can lead to organ failure and premature death. With little to no treatment options, children and young adults primarily affected by the condition often have … Continue reading Novartis acquisition validates CIRM’s impact on cystinosis treatment
CIRM invests $10 million to build California Cell and Gene Therapy Manufacturing Network
A laboratory at UCLA's current good manufacturing practices facility | Photo credit: Elena Zhukova The California Institute for Regenerative Medicine (CIRM), the world’s largest institution dedicated to regenerative medicine, awarded $10 million to five facilities as part of the first phase to build a California Cell and Gene Therapy Manufacturing Network. The awards include: Application … Continue reading CIRM invests $10 million to build California Cell and Gene Therapy Manufacturing Network
CIRM team shines at ASGCT annual meeting in sunny Los Angeles
The California Institute for Regenerative Medicine (CIRM) team spent a week in sunny Los Angeles spreading awareness of its mission at the American Society of Gene & Cell Therapy (ASGCT) annual meeting. The goal of the meeting is to provide a place for people in the cell and gene therapy field to learn from the … Continue reading CIRM team shines at ASGCT annual meeting in sunny Los Angeles
The Stem Cellar 